Children and adolescents with Crohn's disease (CD) present often with a more complicated
disease course compared to adult patients. In addition, the potential impact of CD on growth …

Objective We aimed to provide an evidence-supported update of the ECCO-ESPGHAN
guideline on the medical management of paediatric Crohn's disease [CD]. Methods We …

Abstract Background and Aims Exclusive enteral nutrition [EEN] is recommended as a first-
line induction therapy for paediatric Crohn's disease [CD] although corticosteroids [CS] are …

Background Controversy exists surrounding the optimal treatment for inducing remission in
active Crohn's disease. Aim To review and update evidence on the effectiveness of enteral …

Objectives Treatment options for patients with Crohn disease (CD) have expanded, but the
use of some of these options in pediatric patients remains controversial. The authors …

Objective In newly diagnosed paediatric patients with moderate-to-severe Crohn's disease
(CD), infliximab (IFX) is initiated once exclusive enteral nutrition (EEN), corticosteroid and …

Abstract Background & Aims We aim to provide guidance for medical treatment of luminal
Crohn's disease in children. Methods We performed a systematic search of publication …

Crohn's disease and ulcerative colitis can be grouped as the inflammatory bowel diseases
(IBD). These conditions have become increasingly common in recent years, including in …

Background Exclusive enteral nutrition [EEN] and corticosteroids [CS] induce similar rates of
remission in mild to moderate paediatric Crohn's disease [CD], but differ with regard to …

Background Many studies have examined the effects of exclusive enteral nutrition (EEN) in
children with Crohn's disease (CD), but corticosteroids are considered a superior therapy …